Document is current
Any future updates will be listed below
-
Authors
Straß, Simon
Geiger, Johanna
Cloos, Natascha
Späth, Nadja
Geiger, Sophia
Schwamborn, Anna
De Oliveira da Cunha, Luciano
Martorelli, Mariella
Guse, Jan-Hinrich
Sandri, Thaisa Lucas
Burnet, Michael https://orcid.org/0000-0003-4311-5441
Laufer, Stefan
- License Information
-
More Information
Article History
Received: 2 December 2022
Accepted: 19 February 2023
First Online: 1 April 2023
Declarations
:
: S.S., J.G., N.C., M.M., S.G., A.S., N.S., L.D.O., J.H.G., T.L.S. are employees of Synovo GmbH. M.B. is general manager of Synovo GmbH. Synovo GmbH holds patent rights to the published structures.
: All study protocols were approved by the local Animal Care and Ethics Committee (Federal government ethics committee, Tübingen, Germany under the licenses 35/9185.81-7/SYN 06/20; 35/9185.81-7/SYN 07/18; and 35/9185.81-7/SYN 11/19). Human blood products used in the in vitro assays (used for cell stimulation, viability, stability and uptake assays) were obtained from the center for transfusion medicine in Tübingen, Germany (Zentrum für Klinische Transfusionmedizin Tübingen GmbH, (ethical approval number ZKT-FoPro202106-2305-01 and ZKT-FoPro202012-2211)).
